COVID-19 Outbreak-Global PD-1 and PD-L1 Inhibitors Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
PD-1 and PD-L1 are groups of checkpoint inhibitors specifically designed for treating cancer. Both PD-1 and PD-L1 are proteins present on the surface of cells. These cells interaction is involved in the suppression of the immune system and occurs to limit the killing of bystander host cells and prevent autoimmune disease. In addition, these checkpoint inhibitors are also active in pregnancy following tissue allografts and in varying types of cancer.
The PD-1 and PD-L1 Inhibitors market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the PD-1 and PD-L1 Inhibitors industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The PD-1 and PD-L1 Inhibitors market can be split based on product types, major applications, and important countries as follows:
Key players in the global PD-1 and PD-L1 Inhibitors market covered in Chapter 12:
Boehringer Ingelheim
Zhaoke Pharmaceutical
WuXi AppTec
Merck
Tesaro
Roche
Innovent Biologics
Bristol-Myers Squibb
Pfizer
Harbin Gloria Pharmaceuticals
Biocad
Novartis
Shanghai Junshi Biosciences
Genor Biopharma
3D Medicines
Johnson & Johnson
Jiangsu Hengrui Medicine
AstraZeneca
CytomX
Beigene
ALPHAMAB ONCOLOGY
In Chapter 4 and 14.1, on the basis of types, the PD-1 and PD-L1 Inhibitors market from 2015 to 2025 is primarily split into:
K Drugs
O Drugs
T Drugs
B Drugs
I Drugs
In Chapter 5 and 14.2, on the basis of applications, the PD-1 and PD-L1 Inhibitors market from 2015 to 2025 covers:
Gastric Tumor
Colorectal Cancer
Hodgkin'S Lymphoma
Non-Small Cell Lung Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Hepatoma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 PD-1 and PD-L1 Inhibitors Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of PD-1 and PD-L1 Inhibitors
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the PD-1 and PD-L1 Inhibitors industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global PD-1 and PD-L1 Inhibitors Market Size, 2015 – 2020
2.1.2 Global PD-1 and PD-L1 Inhibitors Market Size by Type, 2015 – 2020
2.1.3 Global PD-1 and PD-L1 Inhibitors Market Size by Application, 2015 – 2020
2.1.4 Global PD-1 and PD-L1 Inhibitors Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on PD-1 and PD-L1 Inhibitors Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of PD-1 and PD-L1 Inhibitors Analysis
3.2 Major Players of PD-1 and PD-L1 Inhibitors
3.3 PD-1 and PD-L1 Inhibitors Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
3.3.3 Labor Cost of PD-1 and PD-L1 Inhibitors
3.4 Market Distributors of PD-1 and PD-L1 Inhibitors
3.5 Major Downstream Buyers of PD-1 and PD-L1 Inhibitors Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global PD-1 and PD-L1 Inhibitors Market, by Type
4.1 Global PD-1 and PD-L1 Inhibitors Value and Market Share by Type (2015-2020)
4.2 Global PD-1 and PD-L1 Inhibitors Production and Market Share by Type (2015-2020)
4.3 Global PD-1 and PD-L1 Inhibitors Value and Growth Rate by Type (2015-2020)
4.3.1 Global PD-1 and PD-L1 Inhibitors Value and Growth Rate of K Drugs
4.3.2 Global PD-1 and PD-L1 Inhibitors Value and Growth Rate of O Drugs
4.3.3 Global PD-1 and PD-L1 Inhibitors Value and Growth Rate of T Drugs
4.3.4 Global PD-1 and PD-L1 Inhibitors Value and Growth Rate of B Drugs
4.3.5 Global PD-1 and PD-L1 Inhibitors Value and Growth Rate of I Drugs
4.4 Global PD-1 and PD-L1 Inhibitors Price Analysis by Type (2015-2020)
5 PD-1 and PD-L1 Inhibitors Market, by Application
5.1 Downstream Market Overview
5.2 Global PD-1 and PD-L1 Inhibitors Consumption and Market Share by Application (2015-2020)
5.3 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Gastric Tumor (2015-2020)
5.3.2 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Colorectal Cancer (2015-2020)
5.3.3 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Hodgkin'S Lymphoma (2015-2020)
5.3.4 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Non-Small Cell Lung Cancer (2015-2020)
5.3.5 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Urothelial Carcinoma (2015-2020)
5.3.6 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Renal Cell Carcinoma (2015-2020)
5.3.7 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Hepatoma (2015-2020)
5.3.8 Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Other (2015-2020)
6 Global PD-1 and PD-L1 Inhibitors Market Analysis by Regions
6.1 Global PD-1 and PD-L1 Inhibitors Sales, Revenue and Market Share by Regions
6.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Regions (2015-2020)
6.1.2 Global PD-1 and PD-L1 Inhibitors Revenue by Regions (2015-2020)
6.2 North America PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.3 Europe PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.6 South America PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
7 North America PD-1 and PD-L1 Inhibitors Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America PD-1 and PD-L1 Inhibitors Sales, Revenue and Market Share by Countries
7.2.1 North America PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
7.2.2 North America PD-1 and PD-L1 Inhibitors Revenue by Countries (2015-2020)
7.3 United States PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.4 Canada PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.5 Mexico PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
8 Europe PD-1 and PD-L1 Inhibitors Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe PD-1 and PD-L1 Inhibitors Sales, Revenue and Market Share by Countries
8.2.1 Europe PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
8.2.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Countries (2015-2020)
8.3 Germany PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
8.4 UK PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
8.5 France PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
8.6 Italy PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
8.7 Spain PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
8.8 Russia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
9 Asia Pacific PD-1 and PD-L1 Inhibitors Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific PD-1 and PD-L1 Inhibitors Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
9.2.2 Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Countries (2015-2020)
9.3 China PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.4 Japan PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Korea PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.6 India PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.7 Southeast Asia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.8 Australia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
10 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
10.2.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Countries (2015-2020)
10.3 Saudi Arabia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
10.4 UAE PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
10.5 Egypt PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
10.6 Nigeria PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
10.7 South Africa PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
11 South America PD-1 and PD-L1 Inhibitors Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America PD-1 and PD-L1 Inhibitors Sales, Revenue and Market Share by Countries
11.2.1 South America PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
11.2.2 South America PD-1 and PD-L1 Inhibitors Revenue by Countries (2015-2020)
11.3 Brazil PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
11.4 Argentina PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
11.5 Columbia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
11.6 Chile PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Basic Information
12.1.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.1.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.2 Zhaoke Pharmaceutical
12.2.1 Zhaoke Pharmaceutical Basic Information
12.2.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.2.3 Zhaoke Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.3 WuXi AppTec
12.3.1 WuXi AppTec Basic Information
12.3.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.3.3 WuXi AppTec Production, Value, Price, Gross Margin 2015-2020
12.4 Merck
12.4.1 Merck Basic Information
12.4.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.4.3 Merck Production, Value, Price, Gross Margin 2015-2020
12.5 Tesaro
12.5.1 Tesaro Basic Information
12.5.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.5.3 Tesaro Production, Value, Price, Gross Margin 2015-2020
12.6 Roche
12.6.1 Roche Basic Information
12.6.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.6.3 Roche Production, Value, Price, Gross Margin 2015-2020
12.7 Innovent Biologics
12.7.1 Innovent Biologics Basic Information
12.7.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.7.3 Innovent Biologics Production, Value, Price, Gross Margin 2015-2020
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Basic Information
12.8.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.8.3 Bristol-Myers Squibb Production, Value, Price, Gross Margin 2015-2020
12.9 Pfizer
12.9.1 Pfizer Basic Information
12.9.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.9.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.10 Harbin Gloria Pharmaceuticals
12.10.1 Harbin Gloria Pharmaceuticals Basic Information
12.10.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.10.3 Harbin Gloria Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.11 Biocad
12.11.1 Biocad Basic Information
12.11.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.11.3 Biocad Production, Value, Price, Gross Margin 2015-2020
12.12 Novartis
12.12.1 Novartis Basic Information
12.12.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.12.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.13 Shanghai Junshi Biosciences
12.13.1 Shanghai Junshi Biosciences Basic Information
12.13.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.13.3 Shanghai Junshi Biosciences Production, Value, Price, Gross Margin 2015-2020
12.14 Genor Biopharma
12.14.1 Genor Biopharma Basic Information
12.14.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.14.3 Genor Biopharma Production, Value, Price, Gross Margin 2015-2020
12.15 3D Medicines
12.15.1 3D Medicines Basic Information
12.15.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.15.3 3D Medicines Production, Value, Price, Gross Margin 2015-2020
12.16 Johnson & Johnson
12.16.1 Johnson & Johnson Basic Information
12.16.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.16.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.17 Jiangsu Hengrui Medicine
12.17.1 Jiangsu Hengrui Medicine Basic Information
12.17.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.17.3 Jiangsu Hengrui Medicine Production, Value, Price, Gross Margin 2015-2020
12.18 AstraZeneca
12.18.1 AstraZeneca Basic Information
12.18.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.18.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
12.19 CytomX
12.19.1 CytomX Basic Information
12.19.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.19.3 CytomX Production, Value, Price, Gross Margin 2015-2020
12.20 Beigene
12.20.1 Beigene Basic Information
12.20.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.20.3 Beigene Production, Value, Price, Gross Margin 2015-2020
12.21 ALPHAMAB ONCOLOGY
12.21.1 ALPHAMAB ONCOLOGY Basic Information
12.21.2 PD-1 and PD-L1 Inhibitors Product Introduction
12.21.3 ALPHAMAB ONCOLOGY Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global PD-1 and PD-L1 Inhibitors Market Forecast
14.1 Global PD-1 and PD-L1 Inhibitors Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 K Drugs Market Value and Volume Forecast (2020-2025)
14.1.2 O Drugs Market Value and Volume Forecast (2020-2025)
14.1.3 T Drugs Market Value and Volume Forecast (2020-2025)
14.1.4 B Drugs Market Value and Volume Forecast (2020-2025)
14.1.5 I Drugs Market Value and Volume Forecast (2020-2025)
14.2 Global PD-1 and PD-L1 Inhibitors Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Gastric Tumor Market Value and Volume Forecast (2020-2025)
14.2.2 Colorectal Cancer Market Value and Volume Forecast (2020-2025)
14.2.3 Hodgkin'S Lymphoma Market Value and Volume Forecast (2020-2025)
14.2.4 Non-Small Cell Lung Cancer Market Value and Volume Forecast (2020-2025)
14.2.5 Urothelial Carcinoma Market Value and Volume Forecast (2020-2025)
14.2.6 Renal Cell Carcinoma Market Value and Volume Forecast (2020-2025)
14.2.7 Hepatoma Market Value and Volume Forecast (2020-2025)
14.2.8 Other Market Value and Volume Forecast (2020-2025)
14.3 PD-1 and PD-L1 Inhibitors Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of PD-1 and PD-L1 Inhibitors
Table Product Specification of PD-1 and PD-L1 Inhibitors
Table PD-1 and PD-L1 Inhibitors Key Market Segments
Table Key Players PD-1 and PD-L1 Inhibitors Covered
Figure Global PD-1 and PD-L1 Inhibitors Market Size, 2015 – 2025
Table Different Types of PD-1 and PD-L1 Inhibitors
Figure Global PD-1 and PD-L1 Inhibitors Value ($) Segment by Type from 2015-2020
Figure Global PD-1 and PD-L1 Inhibitors Market Share by Types in 2019
Table Different Applications of PD-1 and PD-L1 Inhibitors
Figure Global PD-1 and PD-L1 Inhibitors Value ($) Segment by Applications from 2015-2020
Figure Global PD-1 and PD-L1 Inhibitors Market Share by Applications in 2019
Figure Global PD-1 and PD-L1 Inhibitors Market Share by Regions in 2019
Figure North America PD-1 and PD-L1 Inhibitors Production Value ($) and Growth Rate (2015-2020)
Figure Europe PD-1 and PD-L1 Inhibitors Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific PD-1 and PD-L1 Inhibitors Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa PD-1 and PD-L1 Inhibitors Production Value ($) and Growth Rate (2015-2020)
Figure South America PD-1 and PD-L1 Inhibitors Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of PD-1 and PD-L1 Inhibitors
Table Upstream Raw Material Suppliers of PD-1 and PD-L1 Inhibitors with Contact Information
Table Major Players Headquarters, and Service Area of PD-1 and PD-L1 Inhibitors
Figure Major Players Production Value Market Share of PD-1 and PD-L1 Inhibitors in 2019
Table Major Players PD-1 and PD-L1 Inhibitors Product Types in 2019
Figure Production Process of PD-1 and PD-L1 Inhibitors
Figure Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Figure Channel Status of PD-1 and PD-L1 Inhibitors
Table Major Distributors of PD-1 and PD-L1 Inhibitors with Contact Information
Table Major Downstream Buyers of PD-1 and PD-L1 Inhibitors with Contact Information
Table Global PD-1 and PD-L1 Inhibitors Value ($) by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Value Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Value Share by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Production by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Production Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Production Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Value ($) and Growth Rate of K Drugs (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Value ($) and Growth Rate of O Drugs (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Value ($) and Growth Rate of T Drugs (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Value ($) and Growth Rate of B Drugs (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Value ($) and Growth Rate of I Drugs (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global PD-1 and PD-L1 Inhibitors Consumption by Application (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Consumption Market Share by Application (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption Market Share by Application (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Gastric Tumor (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Colorectal Cancer (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Hodgkin'S Lymphoma (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Non-Small Cell Lung Cancer (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Urothelial Carcinoma (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Renal Cell Carcinoma (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Hepatoma (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Consumption and Growth Rate of Other (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue (M USD) and Growth (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales by Regions (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Regions (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue (M USD) by Regions (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions in 2015
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions in 2019
Figure North America PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Europe PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Asia-Pacific PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Middle East and Africa PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure South America PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America PD-1 and PD-L1 Inhibitors Revenue (M USD) and Growth (2015-2020)
Table North America PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
Table North America PD-1 and PD-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table North America PD-1 and PD-L1 Inhibitors Revenue (M USD) by Countries (2015-2020)
Table North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure United States PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Canada PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Mexico PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe PD-1 and PD-L1 Inhibitors Revenue (M USD) and Growth (2015-2020)
Table Europe PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
Table Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table Europe PD-1 and PD-L1 Inhibitors Revenue (M USD) by Countries (2015-2020)
Table Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure Germany PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure UK PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure France PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Italy PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Spain PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Russia PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific PD-1 and PD-L1 Inhibitors Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
Table Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table Asia Pacific PD-1 and PD-L1 Inhibitors Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure China PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Japan PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure South Korea PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure India PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Southeast Asia PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Australia PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Middle East PD-1 and PD-L1 Inhibitors Revenue (M USD) and Growth (2015-2020)
Table Middle East PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
Table Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure UAE PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Egypt PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Nigeria PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure South Africa PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure South America PD-1 and PD-L1 Inhibitors Revenue (M USD) and Growth (2015-2020)
Table South America PD-1 and PD-L1 Inhibitors Sales by Countries (2015-2020)
Table South America PD-1 and PD-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table South America PD-1 and PD-L1 Inhibitors Revenue (M USD) by Countries (2015-2020)
Table South America PD-1 and PD-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure Brazil PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Argentina PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure Columbia PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Chile PD-1 and PD-L1 Inhibitors Sales and Growth (2015-2020)
Figure Top 3 Market Share of PD-1 and PD-L1 Inhibitors Companies in 2019
Figure Top 6 Market Share of PD-1 and PD-L1 Inhibitors Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Zhaoke Pharmaceutical Profile
Table Zhaoke Pharmaceutical Product Introduction
Figure Zhaoke Pharmaceutical Production and Growth Rate
Figure Zhaoke Pharmaceutical Value ($) Market Share 2015-2020
Table WuXi AppTec Profile
Table WuXi AppTec Product Introduction
Figure WuXi AppTec Production and Growth Rate
Figure WuXi AppTec Value ($) Market Share 2015-2020
Table Merck Profile
Table Merck Product Introduction
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table Tesaro Profile
Table Tesaro Product Introduction
Figure Tesaro Production and Growth Rate
Figure Tesaro Value ($) Market Share 2015-2020
Table Roche Profile
Table Roche Product Introduction
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Table Innovent Biologics Profile
Table Innovent Biologics Product Introduction
Figure Innovent Biologics Production and Growth Rate
Figure Innovent Biologics Value ($) Market Share 2015-2020
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Product Introduction
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Harbin Gloria Pharmaceuticals Profile
Table Harbin Gloria Pharmaceuticals Product Introduction
Figure Harbin Gloria Pharmaceuticals Production and Growth Rate
Figure Harbin Gloria Pharmaceuticals Value ($) Market Share 2015-2020
Table Biocad Profile
Table Biocad Product Introduction
Figure Biocad Production and Growth Rate
Figure Biocad Value ($) Market Share 2015-2020
Table Novartis Profile
Table Novartis Product Introduction
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table Shanghai Junshi Biosciences Profile
Table Shanghai Junshi Biosciences Product Introduction
Figure Shanghai Junshi Biosciences Production and Growth Rate
Figure Shanghai Junshi Biosciences Value ($) Market Share 2015-2020
Table Genor Biopharma Profile
Table Genor Biopharma Product Introduction
Figure Genor Biopharma Production and Growth Rate
Figure Genor Biopharma Value ($) Market Share 2015-2020
Table 3D Medicines Profile
Table 3D Medicines Product Introduction
Figure 3D Medicines Production and Growth Rate
Figure 3D Medicines Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Jiangsu Hengrui Medicine Profile
Table Jiangsu Hengrui Medicine Product Introduction
Figure Jiangsu Hengrui Medicine Production and Growth Rate
Figure Jiangsu Hengrui Medicine Value ($) Market Share 2015-2020
Table AstraZeneca Profile
Table AstraZeneca Product Introduction
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table CytomX Profile
Table CytomX Product Introduction
Figure CytomX Production and Growth Rate
Figure CytomX Value ($) Market Share 2015-2020
Table Beigene Profile
Table Beigene Product Introduction
Figure Beigene Production and Growth Rate
Figure Beigene Value ($) Market Share 2015-2020
Table ALPHAMAB ONCOLOGY Profile
Table ALPHAMAB ONCOLOGY Product Introduction
Figure ALPHAMAB ONCOLOGY Production and Growth Rate
Figure ALPHAMAB ONCOLOGY Value ($) Market Share 2015-2020
Table Market Driving Factors of PD-1 and PD-L1 Inhibitors
Table Merger, Acquisition and New Investment
Table Global PD-1 and PD-L1 Inhibitors Market Value ($) Forecast, by Type
Table Global PD-1 and PD-L1 Inhibitors Market Volume Forecast, by Type
Figure Global PD-1 and PD-L1 Inhibitors Market Value ($) and Growth Rate Forecast of K Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Volume ($) and Growth Rate Forecast of K Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Value ($) and Growth Rate Forecast of O Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Volume ($) and Growth Rate Forecast of O Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Value ($) and Growth Rate Forecast of T Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Volume ($) and Growth Rate Forecast of T Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Value ($) and Growth Rate Forecast of B Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Volume ($) and Growth Rate Forecast of B Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Value ($) and Growth Rate Forecast of I Drugs (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Market Volume ($) and Growth Rate Forecast of I Drugs (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Gastric Tumor (2020-2025)
Figure Market Volume and Growth Rate Forecast of Gastric Tumor (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Colorectal Cancer (2020-2025)
Figure Market Volume and Growth Rate Forecast of Colorectal Cancer (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hodgkin'S Lymphoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hodgkin'S Lymphoma (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Non-Small Cell Lung Cancer (2020-2025)
Figure Market Volume and Growth Rate Forecast of Non-Small Cell Lung Cancer (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Urothelial Carcinoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Urothelial Carcinoma (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Renal Cell Carcinoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Renal Cell Carcinoma (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hepatoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hepatoma (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Other (2020-2025)
Figure Market Volume and Growth Rate Forecast of Other (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Research Methodology:
PD 1 and PD L1 Inhibitors Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|